Diagnostics and biomarkers use samples, imaging, and compact analytical devices to detect disease or measure biological change. Earlier and more precise results can help guide clinical decisions and follow-up care.
Circulating tumor DNA is DNA shed by tumor cells that is detectable in a person's bloodstream.
The use of digitized pathology images and computational methods, including AI, to analyze tissue and develop or measure biomarkers.
Exosome diagnostic assays analyze exosomes or their contents to detect, monitor, or help diagnose a disease or biological condition.
Liquid biopsy is a diagnostic approach that analyzes tumor-related material in blood or other body fluids to detect or monitor cancer.
Multi-cancer early detection uses tests to identify signals of multiple cancers, often before symptoms appear.
Point-of-care microfluidics and lab-on-a-chip technologies integrate fluid handling and analytical functions into small devices for testing near the patient or outside centralized laboratories.
Spatial biology studies where molecular and cellular features occur within cells, tissues, and other biological samples.
Discover and track organizations, patents, publications, grants, news and more. Get live alerts on new startups, funding rounds and emerging developments.
This site uses cookies to ensure you get the best experience. You can manage our different cookies in the settings below. Cookies Policy